Are you interested in immunological research at the boundary of fundamental and translational research? Do you want to contribute to novel therapies for rheumatoid arthritis (RA)? And at the same time develop your teaching skills? We offer a PhD position in our enthusiastic team of researchers!
Wat ga je doen? Current therapeutic approaches for RA often rely on broad immune suppression. While effective in managing symptoms, this hampers crucial immune responses including vaccine efficacy. Our research indicates that vaccination with antigen-carrying nanoparticles holds promise for long-term RA relief. In this PhD project, you will spearhead the translation of this approach to human patients, investigating how nanoparticulate vaccines interact with RA patient material, considering factors like disease state and medication impact. Your findings will be pivotal in predicting vaccine safety and efficacy for future clinical trials.
The team, led by
Professor Femke Broere, has many years of experience in studying RA and is at the forefront of novel therapies to treat this disease. Embedded in the Immunology group of the
division of Infectious diseases & Immunology, we are an international team of researchers working on a wide range of topics, including veterinary and human immunology and vaccines. As a team, we prioritise effective collaboration, ongoing feedback, and both professional and personal development.
This appointment is for five years, with a commitment of 20% to teaching. As a PhD candidate, you will conduct cutting-edge research, publish findings in peer-reviewed journals, present at conferences, and actively engage in the academic community.